Any current/future new fundraising through debt or equity?

No specific mentions of current or immediate future fundraising through debt or equity in the call transcript. Capex of around Rs 100 to Rs 200 Crores has been done for new fluorochemical products, but no reference to funding sources. Discussions focus on organic growth via capacity utilization and new product commercialization rather than raising funds. Possibility of monetizing wind farm assets is being explored, which could be a source of capital in the future. No explicit guidance or plans shared regarding issuing new equity or raising additional debt during the call.

Any current/future capex/capital investment/strategic investment?

Gujarat Fluorochemicals has undertaken capex of approximately Rs 100 to Rs 200 Crores so far on new fluorochemical products including specialty polymers and other products expected to come into play by 2019. Minor capexes related to grade development work have been completed; specialty polymers are in qualification stages and expected to start contributing commercially within 6-8 months from the next quarter. The strategy involves increasing utilization of TFE monomer beyond current capacity by 2019, substituting higher per tonne TFE contributing items. Significant bottom-line improvements are

Future growth expectations in sales/revenue/volumes?

New specialty polymers and fluoropolymers are expected to start contributing significantly from the next quarter onwards, with a full impact over 4-8 quarters. Qualification of specialty polymers is lengthy, but once commercialized, full capacity utilization can be reached quickly. The company aims to reach near full capacity utilization of new fluoropolymers within the next two years. Capex of approximately Rs 100-200 Crores is underway for new fluorochemical products, expected to come into play by calendar year 2019. Strategy focuses on maximizing utilization of TFE monomer beyond current ca

Future growth expectations in earnings/operating earnings/profits/EPS?

New speciality polymers and fluoropolymers are expected to start contributing from the next quarter and will pick up substantially over the next 4-8 quarters. Full capacity utilization of new fluoropolymers is anticipated within 2 years, leading to improved product mix and higher realizations. Approximately Rs 100-200 Crores capex has been made on new fluorochemicals, with some products expected to commercialize by calendar year 2019. Strategy aims to increase utilization of TFE monomer and substitute higher per tonne TFE contributing items, leading to improved margins. By calendar year 2019,

GFLQ3 FY17Finance

GFL Q3 FY17 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹51.67P/E: 9.4Market Cap: ₹568 CrSector: Finance

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

New specialty polymers and fluoropolymers are expected to start contributing significantly from the next quarter onwards, with a full impact over 4-8 quarters.
Qualification of specialty polymers is lengthy, but once commercialized, full capacity utilization can be reached quickly.
The company aims to reach near full capacity utilization of new fluoropolymers within the next two years.
Capex of approximately Rs 100-200 Crores is underway for new fluorochemical products, expected to come into play by calendar year 2019.
Strategy focuses on maximizing utilization of TFE monomer beyond current capacity and shifting product mix for higher contribution.
Significant bottom-line improvements are anticipated by calendar year 2019.
PTFE capacity utilization is currently around 60-75%, aiming for 100% in 4-5 quarters.
Value-added product mix is increasing with a potential 2.5-3x increase in EBITDA over two years due to capacity utilization and product addition.

Margin guidance

Category 3

New speciality polymers and fluoropolymers are expected to start contributing from the next quarter and will pick up substantially over the next 4-8 quarters.
Full capacity utilization of new fluoropolymers is anticipated within 2 years, leading to improved product mix and higher realizations.
Approximately Rs 100-200 Crores capex has been made on new fluorochemicals, with some products expected to commercialize by calendar year 2019.
Strategy aims to increase utilization of TFE monomer and substitute higher per tonne TFE contributing items, leading to improved margins.
By calendar year 2019, significant bottom-line improvement is expected.
At current EBITDA (Rs 300-350 Crores), full capacity utilization along with new plants could increase EBITDA by 2.5 to 3 times over 2 years.
Growth drivers include higher capacity utilization of PTFE, increased value-added product mix, and new fluoropolymer commercialization.

See what GFL management said on margin guidance — free account, 30 seconds.

Fundraise plans

No specific mentions of current or immediate future fundraising through debt or equity in the call transcript.
Capex of around Rs 100 to Rs 200 Crores has been done for new fluorochemical products, but no reference to funding sources.
Discussions focus on organic growth via capacity utilization and new product commercialization rather than raising funds.
Possibility of monetizing wind farm assets is being explored, which could be a source of capital in the future.
No explicit guidance or plans shared regarding issuing new equity or raising additional debt during the call.

Order book

The transcript provided does not explicitly mention the current or expected order book or pending orders for Gujarat Fluorochemicals Limited. However, key points related to business outlook include: - Specialty polymers and new fluoropolymers qualification processes are underway; commercial contributions expected from the next quarter. - Capex of approximately Rs 100-200 Crores invested in new fluorochemical products. - Full capacity utilization of PTFE and new fluoropolymers expected within 4-8 quarters (about 1 to 2 years). - Significant bottom-line improvement anticipated in calendar year 2019 driven by enhanced product mix and capacity utilization. - Growth driven by end-user industries including both pharmaceutical and agriculture sectors for fluoro specialities. - The strategy focuses on increasing utilization of TFE monomer and expanding product portfolio to improve margins. No direct numeric order book figures or pending order values are disclosed in the provided content.

See what GFL management said on order book — free account, 30 seconds.

Capex plans

Yes

Gujarat Fluorochemicals has undertaken capex of approximately Rs 100 to Rs 200 Crores so far on new fluorochemical products including specialty polymers and other products expected to come into play by 2019.
Minor capexes related to grade development work have been completed; specialty polymers are in qualification stages and expected to start contributing commercially within 6-8 months from the next quarter.
The strategy involves increasing utilization of TFE monomer beyond current capacity by 2019, substituting higher per tonne TFE contributing items.
Significant bottom-line improvements are anticipated in calendar year 2019 due to these new fluoropolymers and capacity utilization gains.
Plans include moving up the value chain with new value-added fluoropolymers and maximizing capacity utilization over the next 2 years.
Management is exploring options to monetize wind farm assets, which could be valued significantly higher than investments made; updates expected after a quarter.

Track GFL — get its next earnings analysis in your feed

How does GFL rank vs peers in Finance?

Pro feature

ThisGFL

Rev 3Mar 3

See where GFL sits in FinanceSee which companies these are, and every other name in the sector.Open rankings

How does GFL rank in Finance?

Compare GFL against every Finance company (Q3 FY17) on revenue, margins and earnings-call signals.

View Finance leaderboard →

What GFL's management said in earlier quarters

Others in Finance this season

Industrial Investment Trust Ltd (Q2 FY27)
Revenue from Operations (Standalone) for Q2 Sept 30, 2026: ₹1,078.16 lakhs, vs. Key results statement takeaways from Industrial Investment Trust Ltd's Q2 FY27 e
MASK INVESTMENTS (Q2 FY27)
The Cash Flow Statement (page 6) shows a significant decrease in unsecured loans by ₹27.65 lakhs during the half year ended 30th September 2026, indicating…
Muthoot Finance Ltd (Q2 FY27)
Total Income: ₹100,108 Mn (up 36% YoY from ₹72,990 Mn) . Key investor presentation takeaways from Muthoot Finance Ltd's Q2 FY27 investor presentation — and how
Nahar Capital & Financial Services Ltd (Q2 FY27)
1,305.36 lakhs implies an operating margin of approximately 84.5% (1,305.36 / 1,544.82) . Key results statement takeaways from Nahar Capital & Financial Service

Compare:vs Bajaj Finance vs Bajaj Finserv vs Shriram Finance Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

GFL Q3 FY17 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does GFL rank in Finance?

Continue your research

What GFL's management said in earlier quarters

Others in Finance this season